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Summary
Background: Compliance behavior depends on the specific clinical situation, the
nature of the illness, and the treatment program. The aim of this study was to
determine the rate of drug compliance in families caring for a child or adolescent with
epilepsy and to describe some associated factors.
Methods: All the patients with epilepsy under 18 years of age who were attending the
Motahary Clinic of Shiraz for a six-month period and their families were interviewed.
Results: The total number of participants was 181 patients. Drug compliance was
satisfactory in 72.4% of the patients. Etiology of epilepsy, mono-therapy versus poly-
therapy, duration of the disease, age of the patient, accompanying disease, parental
smoking, parental education and living in urban versus rural areas did not significantly
influence the drug compliance but maternal age was significantly higher in patients
with poor compliance. Also, patients with positive family history of epilepsy had more
noncompliance. Moreover, family size had a significant effect on drug compliance.
Finally, patients using phenobarbital were more complaint than other patients.
Conclusions: In this study, drug compliance was satisfactory in almost three-fourths
of the patients with epilepsy. There was no significant association between noncom-
pliance and the cause of epilepsy, duration of the disease, socio-economic status
(parental smoking, living place, education) and number of drugs used to treat the
illness. But paying attention to medication education for patients and parents,
decreasing the complexity of the treatment regimen and younger possibly more
motivated mothers in a small family, increased the drug compliance.
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Compliance is the extent to which a person’s beha-
vior coincides with medical or health advices. Com-
pliance behavior depends on the specific clinical* Tel.: +98 711 6265024; fax: +98 711 6265024.
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oi:10.1016/j.seizure.2005.05.003situation, the nature of the illness, and the treat-
ment program.1
The reasons for noncompliance may include dis-
comfort resulting from treatment, expense of treat-
ment, decisions based on personal judgments about
the effectiveness of the proposed treatment, mala-
daptive coping styles (e.g., denial of illness), or
mental disorders.1by Elsevier Ltd. All rights reserved.
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showgood compliancewith theirmedication because
a neglect of medical treatment may cause epileptic
seizures. However, Chander et al. found that adoles-
cents with epilepsy showed poor compliance,2 and in
two other studies one-third of the adolescents with
epilepsy showed poor compliance.3,4
The aim of this study was to determine the rate of
drug compliance in families caring for a child or
adolescent with epilepsy according to their self-
report of medication usage and to describe some
factors that affect drug compliance.Methods
All the patients with epilepsy under 18 years of age
who were attending the Motahary Clinic of Shiraz
University of Medical Sciences from January 2004 to
June 2004 and their families were interviewed after
signing an informed consent in this cross-sectional
study. The data were collected by means of inter-
view with the parents and/or patients. The col-
lected data consisted of items on the following
topics: compliance for medication taking according
to their self or parental report, the subjective
reason for noncompliance (including irregular tak-
ing, errors of dosage and partial or total omission),
sex, age, duration of disease, treatment regimen,
associated illness (cerebral palsy and/or mental
retardation), family history of epilepsy, sib ship size,
age and educational level of parents, history of
parental smoking and living place. Drug compliance
was considered as satisfactory if the patient took
the medication in correct dosage, regularly and as
planned for him/her either by his/her own or given
by the parents based on their yes/no response to the
questions about the above-mentioned items.
Frequencies and description statistics were com-
puted. The connections between the above-men-
tioned factors to drug compliance were analyzed by
Pearson chi-square, logistic regression and T-test.Results
The total number of participants was 181 patients.
Their mean age was 7  4.6 years. The mean age of
the onset of their disease was 4.9  4.2 years. The
sex ratio (male to female) of these patients was
1.29. The etiology of epilepsy was specified in 21.5%
of the patients, but epilepsy was idiopathic in 78.5%
of them. Epilepsy in 87.3% of the patients was
generalized, in 8.3% partial and in 4.4% unclassified.
The most common types of epilepsy were general-
ized tonic—clonic seizures (36.5%), myoclonic sei-
zures (19.9%), and tonic seizures (17%).The most common drugs prescribed were pheno-
barbital (33.7%), which was prescribed once at night
(q.h.s.) and carbamazepine (27.6%) and valproic
acid (18.8), which were prescribed twice or thrice
a day (b.i.d./t.i.d.). In 10.5% of the patients, two
drugs were used to control the disease, and in 6.1%
of them more than two drugs were used.
Drug compliance was satisfactory in 72.3% and
was poor in 27.7% of the patients according to their
self or parental report. Five percent of the patients
refused to participate, who were omitted from the
study. The reason for noncompliance was minor drug
side effects (drowsiness, gastro-intestinal upset) in
7.5% of them but 92.5% of noncompliant patients did
not adhere to the treatment due to personal judg-
ment about the advantages and disadvantages of
the proposed treatment, or denial of illness as their
coping style.
Drug compliance in patients with idiopathic epi-
lepsy did not differ significantly from the patients
with symptomatic epilepsy (P = 0.428). Compliance
in patients on mono-therapy did not differ signifi-
cantly from other patients (P = 0.631). Duration of
the disease did not have a significant effect on com-
pliance (2.4  1.9 years in the patients with poor
compliance in comparison to 2.2  2.4 years in the
patients with good compliance, P = 0.576). Compli-
ance was not significantly different in children (less
than 12 years old) and adolescents (P = 0.07). Accom-
panying disease (cerebral palsy or mental retarda-
tion) (P = 0.937), parental smoking (P = 0.115),
parental education (P > 0.05), living in urban versus
rural areas (P = 0.394) did not significantly influence
the compliance but maternal age was significantly
higher in patients with poor compliance (P = 0.043
with logistic regression and P = 0.04 with T-test). It
was 26.2  6.5 years in patients with poor compli-
ance and 24  5.6 years in others.
Also, patients with positive family history of
epilepsy had more noncompliance than patients
with negative family history (32.8% versus 18.3%,
P = 0.029). Family size also had a significant effect
on compliance (with logistic regression: P = 0.0001,
B = 0.391). In patients with poor compliance,
family size was 6  2 persons and in others it was
4.6  1.6. Finally, patients using phenobarbital
which was prescribed q.h.s. were more complaint
than those using carbamazepine or valproic acid
which were prescribed twice or thrice daily (88%
versus 67.1%, P = 0.004).Discussion
Compliance, also known as adherence, is the deg-
ree to which a patient carries out the clinical
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pliance behavior depends on the specific clinical
situation, the nature of the illness, and the treat-
ment program. An increased complexity of treat-
ment regimen, as well as an increased number of
required behavioral changes, appears to be asso-
ciated with noncompliance.1
In this study, drug compliance was satisfactory in
almost three-fourths of the patients with epilepsy.
This rate is higher than what was seen in the ado-
lescents previously.3,4 At the first look, it may seem
that because all the children and adolescents were
included in this study, and parents play a more
active role in the treatment program in children,
compliance was higher in this study, but there was
no significant difference between compliance of
children (less than 12 years old) and adolescents
in this study.
In this study, there was not significant association
between noncompliance and the cause of epilepsy
(idiopathic versus symptomatic), duration of dis-
ease, and socio-economic status (parental smoking,
living place, education). However, higher maternal
age, larger family size and positive family history of
epilepsy were significantly associated with noncom-
pliance. These findings signify the role of parents,
especially mothers in caring for children with epi-
lepsy. Besides, appropriate family planning, espe-
cially in families having a previous diseased child,
helps improving the compliance with treatment in
families caring for a child with a chronic disease like
epilepsy.
Also, an increased complexity of the drug regi-
men was associated with noncompliance, as the
patients with once daily regimen had more compli-
ance than others. In a previous study, it was
observed that compliance is enhanced with twice
daily dosage as compared to three or more times
daily dosages.5 It seems that formulating the antic-
onvulsant drugs in a way that they could be pre-
scribed once daily may increase the drug
compliance in the patients with epilepsy.
Interestingly, the number of the drugs used to
treat the illness,was not significantly associatedwith
noncompliance. In contrast, being on mono-therapy
was described as a strong predictor of noncompliance
in the research done by Buck et al.6 However, it is
important to clearly and precisely determine the role
of various aspects of complexity of the drug regimen
in regard to treatment compliance in the patients
with epilepsy in future studies.
To improve and ensure compliance of epileptic
children and adolescents and their families, payingattention to psychological health of the child,7
group education,8 medication education for
patients and parents, especially through written
information,9 and support from parents and physi-
cians4,10,11 are important and useful. Also, decreas-
ing the complexity of the treatment regimen and
younger and possibly more motivated mothers in a
small family with appropriate family planning are
the factors that increase the drug compliance of
these patients and their families.Acknowledgements
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